Bristol Myers’ stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer’s treatment, even ...
Shares of drugmaker Bristol Myers Squibb were up almost 6% as of Wednesday afternoon, despite a delay in a late-stage study ...
Coronary Microvascular Dysfunction is a conditioned that often causes chest pains due to disrupted blood flow.
Bristol Myers will enroll more patients in its Cobenfy Alzheimer's psychosis study after site irregularities, with ...
The phase 3 comeback story that Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year.
KGET Bakersfield on MSN
17's Tami Mlcoch at Bristol Hospice Light Up a Life
17's Tami Mlcoch at Bristol Hospice Light Up a Life ...
Bristol-Myers Squibb shares gained after the company announced that it will enroll additional patients in the ADEPT-2 study.
The council is working to "raise awareness of the risks" ...
PC Rehaan Akhtar had been on a night out with friends in Bristol and was last seen in the early hours of 23 November. | ITV ...
Bristol student Vijay Kumar died after being stabbed in Worcester. His family say he brought 'energy, joy and laughter' to ...
7hon MSN
Bristol Regional Medical Center first in region to offer advanced heart condition diagnostics tool
BRISTOL, Tenn. (WJHL) — Ballad Health announced this week that the Bristol Regional Medical Center (BRMC) is the first ...
Bristol Myers Squibb will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results